AbbVie Income Tax Expense from 2010 to 2024

ABBV Stock  USD 182.10  1.75  0.97%   
AbbVie Income Tax Expense yearly trend continues to be fairly stable with very little volatility. Income Tax Expense will likely drop to about 996.2 M in 2024. During the period from 2010 to 2024, AbbVie Income Tax Expense regression line of quarterly data had mean square error of 949357.2 T and geometric mean of  979,680,994. View All Fundamentals
 
Income Tax Expense  
First Reported
2010-12-31
Previous Quarter
172 M
Current Value
388 M
Quarterly Volatility
351.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.1 B, Interest Expense of 1.1 B or Selling General Administrative of 8 B, as well as many exotic indicators such as Short Term Coverage Ratios of 5.75, Price Earnings Ratio of 59.09 or Price To Sales Ratio of 3.39. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
  
This module can also supplement AbbVie's financial leverage analysis and stock options assessment as well as various AbbVie Technical models . Check out the analysis of AbbVie Correlation against competitors.

Latest AbbVie's Income Tax Expense Growth Pattern

Below is the plot of the Income Tax Expense of AbbVie Inc over the last few years. It is AbbVie's Income Tax Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
Income Tax Expense10 Years Trend
Very volatile
   Income Tax Expense   
       Timeline  

AbbVie Income Tax Expense Regression Statistics

Arithmetic Mean928,229,938
Geometric Mean979,680,994
Coefficient Of Variation101.19
Mean Deviation727,864,084
Median1,204,000,000
Standard Deviation939,294,125
Sample Variance882273.5T
Range3.6B
R-Value0.03
Mean Square Error949357.2T
R-Squared0.0008
Significance0.92
Slope6,031,173
Total Sum of Squares12351828.3T

AbbVie Income Tax Expense History

2024996.2 M
20231.4 B
20221.6 B
20211.4 B
2020-1.2 B
2019544 M
2018-490 M

About AbbVie Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include AbbVie income statement, its balance sheet, and the statement of cash flows. AbbVie investors use historical funamental indicators, such as AbbVie's Income Tax Expense, to determine how well the company is positioned to perform in the future. Although AbbVie investors may use each financial statement separately, they are all related. The changes in AbbVie's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AbbVie's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on AbbVie Financial Statements. Understanding these patterns can help to make the right decision on long term investment in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Income Tax Expense1.4 B996.2 M

Pair Trading with AbbVie

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AbbVie position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will appreciate offsetting losses from the drop in the long position's value.

Moving together with AbbVie Stock

  0.63CLVRW Clever Leaves HoldingsPairCorr

Moving against AbbVie Stock

  0.89MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.89VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.83MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.83ME 23Andme HoldingPairCorr
  0.82KA Kineta Inc Report 29th of March 2024 PairCorr
The ability to find closely correlated positions to AbbVie could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AbbVie when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AbbVie - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AbbVie Inc to buy it.
The correlation of AbbVie is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AbbVie moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AbbVie Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AbbVie can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether AbbVie Inc is a strong investment it is important to analyze AbbVie's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AbbVie's future performance. For an informed investment choice regarding AbbVie Stock, refer to the following important reports:
Check out the analysis of AbbVie Correlation against competitors.
Note that the AbbVie Inc information on this page should be used as a complementary analysis to other AbbVie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for AbbVie Stock analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Valuation
Check real value of public entities based on technical and fundamental data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Is AbbVie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AbbVie. If investors know AbbVie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AbbVie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.67)
Dividend Share
5.99
Earnings Share
2.72
Revenue Per Share
30.723
Quarterly Revenue Growth
(0.05)
The market value of AbbVie Inc is measured differently than its book value, which is the value of AbbVie that is recorded on the company's balance sheet. Investors also form their own opinion of AbbVie's value that differs from its market value or its book value, called intrinsic value, which is AbbVie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AbbVie's market value can be influenced by many factors that don't directly affect AbbVie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AbbVie's value and its price as these two are different measures arrived at by different means. Investors typically determine if AbbVie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AbbVie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.